RUNX1 and metabolic dysfunction-associated steatotic liver disease: Since RUNX1 has been proposed as a regulator for inflammation (TLR4-mediated inflammation), angiogenesis (via VEGF), and hematopoiesis, this lncRNA has been investigated for its role in NAFLD [88, 89].